Gesine Meyer-Rath
Cited by
Cited by
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
The impact and cost of scaling up GeneXpert MTB/RIF in South Africa
G Meyer-Rath, K Schnippel, L Long, W MacLeod, I Sanne, W Stevens, ...
PloS one 7 (5), e36966, 2012
HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
PLoS Medicine 9 (7), e1001259, 2012
Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study
K Kranzer, SD Lawn, G Meyer-Rath, A Vassall, E Raditlhalo, ...
Public Library of Science 9 (8), e1001281, 2012
Scaling up Xpert MTB/RIF technology: the costs of laboratory‐ vs. clinic‐based roll‐out in South Africa
K Schnippel, G Meyer‐Rath, L Long, W MacLeod, I Sanne, WS Stevens, ...
Tropical Medicine & International Health 17 (9), 1142-1151, 2012
Changing the South African national antiretroviral therapy guidelines: the role of cost modelling
G Meyer-Rath, LF Johnson, Y Pillay, M Blecher, AT Brennan, L Long, ...
PLoS One 12 (10), e0186557, 2017
HIV treatment as prevention: modelling the cost of antiretroviral treatment—state of the art and future directions
G Meyer-Rath, M Over
PLoS medicine 9 (7), e1001247, 2012
Attrition through multiple stages of pre-treatment and ART HIV care in South Africa
MP Fox, K Shearer, M Maskew, G Meyer-Rath, K Clouse, I Sanne
PLoS One 9 (10), e110252, 2014
Prospects for HIV control in South Africa: a model-based analysis
LF Johnson, C Chiu, L Myer, MA Davies, RE Dorrington, LG Bekker, ...
Global health action 9 (1), 30314, 2016
The per-patient costs of HIV services in South Africa: systematic review and application in the South African HIV investment case
G Meyer-Rath, C van Rensburg, C Chiu, R Leuner, L Jamieson, S Cohen
PloS one 14 (2), e0210497, 2019
Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa
Y Jo, L Jamieson, I Edoka, L Long, S Silal, JRC Pulliam, H Moultrie, ...
Open Forum Infectious Diseases 8 (3), ofab040, 2021
Evidence for scaling up HIV treatment in sub-Saharan Africa: a call for incorporating health system constraints
E Mikkelsen, JAC Hontelez, MPM Jansen, T Bärnighausen, K Hauck, ...
PLoS medicine 14 (2), e1002240, 2017
Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa
G Meyer-Rath, AT Brennan, MP Fox, T Modisenyane, N Tshabangu, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (3), 322-328, 2013
Optimal HIV testing strategies for South Africa: a model-based evaluation of population-level impact and cost-effectiveness
LF Johnson, C van Rensburg, C Govathson, G Meyer-Rath
Scientific reports 9 (1), 12621, 2019
Diagnosing Xpert MTB/RIF-negative TB: Impact and cost of alternative algorithms for South Africa
K Schnippel, G Meyer-Rath, L Long, WS Stevens, I Sanne, S Rosen
South African Medical Journal 103 (2), 101-106, 2013
Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa
CAB Pearson, SP Silal, MWZ Li, J Dushoff, BM Bolker, S Abbott, ...
MedRxiv, 2021.12. 19.21268038, 2021
Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case
G Meyer-Rath, C Van Rensburg, B Larson, L Jamieson, S Rosen
PLoS One 12 (10), e0186496, 2017
Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV program planning
G Meyer-Rath, JB McGillen, DF Cuadros, TB Hallett, S Bhatt, N Wabiri, ...
Aids 32 (8), 957-963, 2018
Good treatment outcomes among foreigners receiving antiretroviral therapy in Johannesburg, South Africa
K McCarthy, MF Chersich, J Vearey, G Meyer-Rath, A Jaffer, S Simpwalo, ...
International journal of STD & AIDS 20 (12), 858-862, 2009
Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
C Chiu, LF Johnson, L Jamieson, BA Larson, G Meyer-Rath
BMC Public Health 17, 1-9, 2017
The system can't perform the operation now. Try again later.
Articles 1–20